Form DEFA14A MICROCHIP TECHNOLOGY
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
Filed by the Registrant | ý | ||||
Filed by a Party other than the Registrant | o | ||||
| Check the appropriate box: | |||||
| o | Preliminary Proxy Statement | ||||
| o | Confidential, for use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | ||||
| o | Definitive Proxy Statement | ||||
| ý | Definitive Additional Materials | ||||
| o | Soliciting Material Pursuant to § 240.14a-12 | ||||
Microchip Technology Incorporated
(Name of Registrant as Specified In Its Charter)
____________________________________________________________________
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (check the appropriate box): | ||||||||
ý | No fee required. | |||||||
¨ | Fee paid previously with preliminary materials. | |||||||
¨ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. | |||||||

MICROCHIP TECHNOLOGY INCORPORATED
2355 West Chandler Boulevard, Chandler, Arizona 85224-6199
On July 7, 2025, Microchip Technology Incorporated filed a Definitive Proxy Statement for its annual meeting of stockholders to be held on August 19, 2025 with the Securities and Exchange Commission. The following slides provide additional information regarding an executive compensation matter and should be read together with the disclosures in the Definitive Proxy Statement.




Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 3 analog stocks to buy amid accelerating demand: UBS
- Corinex and Plexigrid team up to deliver the most accurate digital-twin solution for grid visibility and flexibility to date
- MRX1 Successfully Delivered to Clinical Trial Site
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share